Aprea Therapeutics, Inc. (APRE): Insider Trading, Congress Trades & Research | Tormere

APRE

$0.51+3.17%visit website

Aprea Therapeutics, Inc.

Market Cap

$6M

Live price × Finnhub shares (2026-09-18)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

1.72

60mo monthly vs SPY

P/E (TTM)

—

Price / TTM diluted EPS

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

—

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	Q3 FY2026 Sep 30, 2026	TTM Sep 30, 2026
Research & development	1,009	1,611	2,462	3,341	8,423
Total operating expenses	2,646	3,430	4,032	5,174	15,283
Operating income	(2,643)	(3,430)	(4,032)	(5,174)	(15,279)
Income tax	0.00	0.00	0.00	0.00	0.00
Net income	(2,456)	(3,288)	(3,591)	(4,810)	(14,145)
EPS (basic) ($)		(0.22)	(0.07)	(0.09)	—
EPS (diluted) ($)		(0.22)	(0.07)	(0.09)	—
Weighted avg. shares (basic)		14,685	53,484	53,681
Weighted avg. shares (diluted)		14,685	53,484	53,681

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Nov 4, 2026, period ended Sep 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 29 more quarters, back to Sep 2018, with Tormere Pro.

Signals

Insider Velocity

no recent activity

purchases / sales, 90d

Market & Alt Data

News

15

recent articles

No Form 4 transactions on record.

Recent News

Aprea Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference

Yahoo · 2026-11-05

Aprea Therapeutics, Inc. (APRE) Stock Price, News, Quote & History

Yahoo! Finance Canada · 2026-11-04

Aprea Therapeutics Announces Third Quarter 2026 Financial Results

Yahoo · 2026-11-04

Aprea Therapeutics Q3 EPS $(0.09) Misses $(0.07) Estimate

Benzinga · 2026-11-04

Aprea Therapeutics to Host Pre-ESMO Virtual Panel on the State of WEE1 Inhibition in Precision Oncology

Yahoo · 2026-10-16

Ladenburg Thalmann Initiates Coverage On Aprea Therapeutics with Buy Rating, Announces Price Target of $2

Benzinga · 2026-10-14

12 Health Care Stocks Moving In Thursday's After-Market Session

Benzinga · 2026-10-08

Aprea Therapeutics to Present at October Conferences

Yahoo Finance · 2026-10-05

Aprea Therapeutics to Present Updated Interim Phase 1 Data on WEE1 Inhibitor APR-1051 in an Oral Presentation at 38th EORTC-NCI-AACR Symposium

Yahoo Finance · 2026-09-22

Aprea Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference

Yahoo Finance · 2026-09-10

Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs

Yahoo Finance · 2026-08-28

Aprea Therapeutics records second consecutive surge, jumping another 22% (APRE:NASDAQ)

Seeking Alpha · 2026-08-25

Aprea Therapeutics (APRE) Edges Higher by 1.34% as Shares Hover Above Key Support - Call Resistance

dars.gov.et · 2026-08-15

Aprea Therapeutics Announces Second Quarter 2026 Financial Results

Yahoo Finance · 2026-08-12

APRE Forecast — Price Target — Prediction for 2027

TradingView · 2026-06-26

Informational purposes only, not investment advice.